🇺🇸 FDA
Patent

US 11617755

Pharmaceutical compositions comprising meloxicam

granted A61KA61K31/415A61K31/4196

Quick answer

US patent 11617755 (Pharmaceutical compositions comprising meloxicam) held by AXSOME THERAPEUTICS, INC. expires Mon Mar 30 2043 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
AXSOME THERAPEUTICS, INC.
Grant date
Tue Apr 04 2023 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Mar 30 2043 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
27
CPC classes
A61K, A61K31/415, A61K31/4196, A61K31/5415, A61K47/02